市場調查報告書
商品編碼
1403401
醫療保健領域的認知功能評估和培訓市場至2030年的預測:按組件、評估、應用、最終用戶和地區的全球分析Cognitive Assessment & Training In Healthcare Market Forecasts to 2030 - Global Analysis By Component (Solutions & Services), Assessment (Pen & Paper Based Assessment, Hosted Assessment & Biometrics Assessment), Application, End User & By Geography |
根據 Stratistics MRC 的資料,2023年全球醫療保健認知評估和培訓市場規模為 34.2 億美元,預測期內年複合成長率為 25.6%,預計到2030年將達到 266.7 億美元。
認知評估和培訓透過評估和增強認知功能在醫療保健中發揮重要作用。這些工具可幫助臨床醫生識別和解決認知功能障礙,並深入了解患者的心理健康狀況。將這些工具涵蓋醫療保健將有助於及早發現認知能力下降並實現個體化介入。
據老年失智症協會表示,到2050年,預計將有超過 1.53 億人患上失智症,而2019年這一數字為 5700 萬。
人口老化加劇
隨著人口老化的擴大,對有效認知健康解決方案的需求不斷增加。因此,醫療保健產業關注創新的評估和培訓計劃,以解決與老齡化相關的認知能力下降、失智症和其他神經退化性疾病。市場見證技術進步和個體化方法的激增,以滿足老齡化人口的特定認知需求,推動認知醫療解決方案的整體成長和開拓。
資料隱私和安全問題
敏感的患者資訊擴大被數位化以用於評估目的,未授權存取和資料外洩的風險構成了重大威脅。問題包括未授權存取個人健康資訊,可能侵犯患者機密以及需要強大的加密措施。由於此類評估通常包括先進技術,因此確保遵守 HIPAA 等資料保護條例對於保護病患隱私和維持對醫療保健生態系統的信任非常重要。
與電子健康記錄(EHR)整合
認知健康資料和 EHR 之間的無縫連接可簡化患者照護,提高診斷準確性並促進個體化介入。這種整合使醫療保健提供者能夠利用全面的患者檔案,促進認知健康的整體方法。隨著對認知健康解決方案的需求增加,與 EHR 系統合作將實現一個有凝聚力和高效的醫療保健生態系統,最終將改善患者的治療結果並擴大認知醫療保健領域。
初期成本高
認知解決方案需要大量的財務投資來實施,這阻礙了普及。創建準確的、經過臨床檢驗的評估,以及製定有效的培訓計劃,需要大量的研發投資。實施安全資料儲存也會增加初期成本。這項挑戰可能會阻礙先進認知技術的整合,並限制對創新評估和培訓工具的取得。
COVID-19 大流行對醫療保健產生了多方面的影響。它對醫療保健領域的認知評估和培訓市場產生了重大影響,增加了對遠距解決方案的關注。封鎖和社交距離措施加速了認知評估和培訓虛擬平台的採用,以滿足家庭醫療保健需求。該行業對數位認知健康工具的需求激增,重塑了市場形勢。
紙筆評估部分預計將在預測期內成為最大的區隔
紙筆評估領域預計將經歷良好的成長。紙筆評估在醫療保健市場的認知評估和培訓領域仍然很普及。儘管技術不斷進步,這些傳統方法仍提供了具有成本效益且廣泛可用的認知功能評估方法。它繼續在認知衰退的基線評估和監測中發揮重要作用。提高認知評估的準確性和效率,同時適應不斷變化的醫療保健趨勢。
預計臨床試驗領域在預測期內的年複合成長率最高。
預計臨床試驗領域在預測期內將出現最高的年複合成長率。這些臨床試驗的重點是評估和改善心理過程,例如記憶力、注意力和解決問題的能力。在醫療保健市場,致力於開發阿茲海默症和認知障礙等疾病的有效干預措施。認知醫療保健的進步繼續受益於該領域的持續研究和創新。
由於人口老化加劇,認知健康意識不斷提高以及技術進步,預計亞太地區將在預測期內佔據最大的市場佔有率。該地區的主要企業包括 Cambridge Cognition Ltd.、CogniFit Inc.、Cogstate Ltd. 和 Brain Resource Company。這些公司迅速擴大其醫療保健基礎設施。政府對醫療保健基礎設施的關注和數位醫療解決方案的採用進一步推動了市場的發展。
由於擴大採用創新技術進行認知評估和增強,預計北美在預測期內將經歷最高的年複合成長率。該市場致力於解決神經系統疾病和促進心理健康,並迅速看到了對個體化、技術主導的解決方案的需求。該地區的主要企業積極與醫療保健提供者合作,提供先進的認知評估工具和培訓計劃,幫助改善患者的整體治療效果並推進神經認知醫療保健實踐。做出貢獻。
According to Stratistics MRC, the Global Cognitive Assessment & Training in Healthcare Market is accounted for $3.42 billion in 2023 and is expected to reach $26.67 billion by 2030 growing at a CAGR of 25.6% during the forecast period. Cognitive assessment and training play crucial roles in healthcare, evaluating and enhancing cognitive functions. These tools help clinicians identify and address cognitive impairments, providing insights into patients' mental health. Integrating these tools into healthcare facilitates early detection of cognitive decline and enables personalized interventions, contributing to more effective patient care and management of conditions like dementia and other cognitive disorders.
According to Alzheimer's Association, more than 153 million individuals will develop dementia by 2050, up from 57 million in 2019.
As the elderly demographic expands, there is a growing demand for effective cognitive health solutions. This has prompted the healthcare industry to focus on innovative assessments and training programs to address age-related cognitive decline, dementia, and other neurodegenerative disorders. The market is witnessing an upsurge in technological advancements and personalized approaches to cater to the specific cognitive needs of the aging population, driving the overall growth and development of cognitive healthcare solutions.
Sensitive patient information is increasingly digitized for assessments, the risk of unauthorized access and data breaches poses a substantial threat. Issues include unauthorized access to personal health information, potential breaches compromising patient confidentiality, and the need for robust encryption measures. As these assessments often involve advanced technologies, ensuring compliance with data protection regulations, such as HIPAA, becomes crucial to safeguarding patient privacy and maintaining trust in the healthcare ecosystem.
Seamless connectivity between cognitive health data and EHR streamlines patient care, enhances diagnostic accuracy, and facilitates personalized interventions. This integration enables healthcare providers to leverage comprehensive patient profiles, fostering a holistic approach to cognitive well-being. As the demand for cognitive health solutions grows, aligning with EHR systems ensures a cohesive and efficient healthcare ecosystem, ultimately improving patient outcomes and advancing the field of cognitive healthcare.
Implementing cognitive solutions requires substantial financial investment, hindering widespread adoption among healthcare providers. The creation of accurate and clinically validated assessments, along with the development of effective training programs, demands substantial research and development investments. Also, implementing secure data storage further contributes to the initial expenses. This challenge may impede the integration of advanced cognitive technologies, limiting access to innovative assessment and training tools.
The COVID-19 pandemic has had multifaceted effects on healthcare. It significantly impacted the Cognitive Assessment and Training in Healthcare Market, with increased focus on remote solutions. Lockdowns and social distancing measures accelerated the adoption of virtual platforms for cognitive assessments and training, addressing the need for at-home healthcare. The industry witnessed a surge in demand for digital cognitive health tools, reshaping the market landscape.
The pen & paper based assessment segment is estimated to have a lucrative growth. Pen and paper-based assessments remain prevalent in the Cognitive Assessment and Training sector within the Healthcare market. Despite technological advancements, these traditional methods offer a cost-effective and widely accessible means of evaluating cognitive functions. They continue to play a crucial role in baseline assessments and monitoring cognitive decline. It enhances accuracy and efficiency in cognitive evaluations while adapting to evolving healthcare trends.
The clinical trials segment is anticipated to witness the highest CAGR growth during the forecast period. These trials focus on assessing and improving mental processes such as memory, attention, and problem-solving. In the healthcare market, they contribute to the development of effective interventions for conditions like Alzheimer's and cognitive impairments. The evolving landscape of cognitive healthcare continues to benefit from ongoing research and innovation in this field.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the increasing aging population, rising awareness of cognitive health, and technological advancements. The region is home for key players such as Cambridge Cognition Ltd., CogniFit Inc., Cogstate Ltd. and Brain Resource Company. These companies are rapidly expanding their healthcare infrastructure. Government's focus on healthcare infrastructure and the adoption of digital health solutions further drive the market.
North America is projected to have the highest CAGR over the forecast period, owing to increasing adoption of innovative technologies for cognitive evaluation and enhancement. With a focus on addressing neurological disorders and promoting mental well-being, the market has witnessed a surge in demand for personalized, technology-driven solutions. Key players in the region are actively collaborating with healthcare providers to deliver advanced cognitive assessment tools and training programs, contributing to the overall improvement of patient outcomes and the advancement of neurocognitive healthcare practices.
Some of the key players profiled in the Cognitive Assessment & Training in Healthcare Market include Cambridge Cognition Ltd, CogniFit Inc, Cogstate Ltd, Eisai Limited, Brain Resource Company, WIRB-Copernicus Group, MedAvante Inc, Quest Diagnostics Incorporated, ProPhase LLC, Signant Health, Linus Health, Posit Science, Clario, Cognetivity Neurosciences, Pear Therapeutics, Akili Interactive Labs and CNS Vital Signs LLC.
In May 2023, Linus Health, a digital health solution provider, announced the result of its digital cognitive assessment solution study with a commonly used, paper-based cognitive test, the Mini-Mental State Examination (MMSE), in detecting cognitive cases of impairment. This solution helps in the earlier identification of cognitive issues.
In January 2022, Eisai Limited announced the launch of CogMate by its Taiwanese and Hong Kong subsidiaries. CogMate is a digital tool for self-assessment of brain health and is expected to be launched in other countries including Singapore.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.